Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
Published January 17, 2024 · Recall initiated: November 17, 2023
Summary
FDA records drug Class I recall D-0220-2024, published January 17, 2024 and initiated November 17, 2023. Recalling firm: InvaGen Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 1240 boxes; Lot: Lot #: NB301030, Exp. Date 03/31/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: powder may leak out of the pouch
What to do
Voluntary: Firm initiated · Letter
Get an email if VIGABATRIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VIGABATRIN
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: NB301030, Exp. Date 03/31/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,January 17, 2024
- FDADesloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, RxJanuary 17, 2024
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for:January 17, 2024
- FDATizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, SrikakulamJanuary 17, 2024
- FDAVitality Polyaxial Screw, 7.5mmx 50mm, REF: 07.02000.118, used with Vitality and Vital Spinal Fixation SystemJanuary 10, 2024
- FDATrilogy Evo and Trilogy Evo O2 Material Numbers BL2110X15B BR2110X18B CA2110X12B DE2100X13B DE2110X13BJanuary 10, 2024
Questions about this recall
Was Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53 recalled?
Yes. FDA published recall D-0220-2024 on January 17, 2024. Reported hazard: Defective Container: powder may leak out of the pouch
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VIGABATRIN.